Search Results

Single-Center TOBA Study's 24-Month Results Presented for Intact Vascular's Tack Endovascular System

November 16, 2017—Intact Vascular, Inc. announced that positive single-center 24-month results from its Tack Optimized Balloon Angioplasty (TOBA) clinical study were presented by Christian Wissgott, MD, at the 2017 VEITHsymposium held November 14–18 in New York, New York.

Twelve-Month TOBA-BTK Results Presented for Intact Vascular's Tack System

May 4, 2016—Intact Vascular, Inc. announced that positive 12-month results from its Tack Optimized Balloon Angioplasty—Below-the-Knee (TOBA-BTK) clinical study were presented at the Society for Cardiovascular Angiography & Interventions 2016 scientific session by Christian Wissgott, MD, Assistant Director at Westküstenklinikum Heide in Heide, Germany.

InspireMD Announces Study on Clinical Benefit and Utility of the CGuard EPS

October 19, 2016—InspireMD, Inc. announced the publication of positive 6-month clinical results on the company’s carotid CGuard double-layered embolic prevention stent (EPS) in patients with symptomatic or high-grade asymptomatic internal carotid artery (ICA) stenosis.

Intact Vascular Completes TOBA-BTK Trial Enrollment

November 4, 2014—Intact Vascular announced the completion of the TOBA-BTK (Tack Optimized Balloon Angioplasty—Below the Knee) study.

Long-Term Data Presented From European Registries of InspireMD's CGuard EPS

November 29, 2018—InspireMD, Inc. announced that updated data on the company's CGuard embolic prevention system (EPS) for the prevention of stroke caused by the treatment of carotid artery disease were presented at the 45th annual VEITHsymposium held November 13–17 in New York, New York.